Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 76

1.

Improving Strength, Power, Muscle Aerobic Capacity, and Glucose Tolerance through Short-term Progressive Strength Training Among Elderly People.

Andersson EA, Frank P, Pontén M, Ekblom B, Ekblom M, Moberg M, Sahlin K.

J Vis Exp. 2017 Jul 5;(125). doi: 10.3791/55518.

PMID:
28715403
2.

Post Activation Potentiation of the Plantarflexors: Implications of Knee Angle Variations.

Gago P, Arndt A, Ekblom MM.

J Hum Kinet. 2017 Jun 22;57:29-38. doi: 10.1515/hukin-2017-0044. eCollection 2017 Jun.

3.

Leukotriene signaling via ALOX5 and cysteinyl leukotriene receptor 1 is dispensable for in vitro growth of CD34+CD38- stem and progenitor cells in chronic myeloid leukemia.

Dolinska M, Piccini A, Wong WM, Gelali E, Johansson AS, Klang J, Xiao P, Yektaei-Karin E, Strömberg UO, Mustjoki S, Stenke L, Ekblom M, Qian H.

Biochem Biophys Res Commun. 2017 Aug 19;490(2):378-384. doi: 10.1016/j.bbrc.2017.06.051. Epub 2017 Jun 13.

4.

Do unfavourable alcohol, smoking, nutrition and physical activity predict sustained leisure time sedentary behaviour? A population-based cohort study.

Nooijen CFJ, Möller J, Forsell Y, Ekblom M, Galanti MR, Engström K.

Prev Med. 2017 Aug;101:23-27. doi: 10.1016/j.ypmed.2017.05.019. Epub 2017 May 18.

PMID:
28529160
5.

Population Pharmacokinetics of Cladribine in Patients with Multiple Sclerosis.

Savic RM, Novakovic AM, Ekblom M, Munafo A, Karlsson MO.

Clin Pharmacokinet. 2017 Mar 2. doi: 10.1007/s40262-017-0516-6. [Epub ahead of print]

PMID:
28255849
6.

Modulation of leukotriene signaling inhibiting cell growth in chronic myeloid leukemia.

Yektaei-Karin E, Zovko A, Nilsson A, Näsman-Glaser B, Kanter L, Rådmark O, Wallvik J, Ekblom M, Dolinska M, Qian H, Stenke L.

Leuk Lymphoma. 2017 Aug;58(8):1903-1913. doi: 10.1080/10428194.2016.1262029. Epub 2016 Dec 8.

PMID:
27931141
7.

Quadriceps and hamstring muscle activity during cycling as measured with intramuscular electromyography.

da Silva JC, Tarassova O, Ekblom MM, Andersson E, Rönquist G, Arndt A.

Eur J Appl Physiol. 2016 Sep;116(9):1807-17. doi: 10.1007/s00421-016-3428-5. Epub 2016 Jul 23.

8.

Assessment of bone marrow lymphocytic status during tyrosine kinase inhibitor therapy and its relation to therapy response in chronic myeloid leukaemia.

El Missiry M, Adnan Awad S, Rajala HL, Al-Samadi A, Ekblom M, Markevän B, Åstrand-Grundström I, Wold M, Svedahl ER, Juhl BR, Bjerrum OW, Haulin I, Porkka K, Olsson-Strömberg U, Hjorth-Hansen H, Mustjoki S.

J Cancer Res Clin Oncol. 2016 May;142(5):1041-50. doi: 10.1007/s00432-015-2101-4. Epub 2016 Jan 8.

PMID:
26746653
9.

Trunk Muscle Activation at the Initiation and Braking of Bilateral Shoulder Flexion Movements of Different Amplitudes.

Eriksson Crommert M, Halvorsen K, Ekblom MM.

PLoS One. 2015 Nov 12;10(11):e0141777. doi: 10.1371/journal.pone.0141777. eCollection 2015.

10.

A novel Lin-CD34+CD38- integrin α2- bipotential megakaryocyte-erythrocyte progenitor population in the human bone marrow.

Wong WM, Dolinska M, Sigvardsson M, Ekblom M, Qian H.

Leukemia. 2016 Jun;30(6):1399-402. doi: 10.1038/leu.2015.300. Epub 2015 Oct 26. No abstract available.

11.

Effect on the Gastrointestinal Absorption of Drugs from Different Classes in the Biopharmaceutics Classification System, When Treating with Liraglutide.

Malm-Erjefält M, Ekblom M, Vouis J, Zdravkovic M, Lennernäs H.

Mol Pharm. 2015 Nov 2;12(11):4166-73. doi: 10.1021/acs.molpharmaceut.5b00278. Epub 2015 Oct 12.

PMID:
26426736
12.

Strength training improves muscle aerobic capacity and glucose tolerance in elderly.

Frank P, Andersson E, Pontén M, Ekblom B, Ekblom M, Sahlin K.

Scand J Med Sci Sports. 2016 Jul;26(7):764-73. doi: 10.1111/sms.12537. Epub 2015 Aug 14.

PMID:
26271931
13.

Low/negative expression of PDGFR-α identifies the candidate primary mesenchymal stromal cells in adult human bone marrow.

Li H, Ghazanfari R, Zacharaki D, Ditzel N, Isern J, Ekblom M, Méndez-Ferrer S, Kassem M, Scheding S.

Stem Cell Reports. 2014 Dec 9;3(6):965-74. doi: 10.1016/j.stemcr.2014.09.018. Epub 2014 Oct 30.

14.

Post activation potentiation can be induced without impairing tendon stiffness.

Gago P, Arndt A, Tarassova O, Ekblom MM.

Eur J Appl Physiol. 2014 Nov;114(11):2299-308. doi: 10.1007/s00421-014-2945-3. Epub 2014 Jul 22.

PMID:
25048072
15.

Passive muscle length changes affect twitch potentiation in power athletes.

Gago P, Marques MC, Marinho DA, Ekblom MM.

Med Sci Sports Exerc. 2014 Jul;46(7):1334-42. doi: 10.1249/MSS.0000000000000245.

PMID:
24389516
16.

A phase 2 trial of ponatinib in Philadelphia chromosome-positive leukemias.

Cortes JE, Kim DW, Pinilla-Ibarz J, le Coutre P, Paquette R, Chuah C, Nicolini FE, Apperley JF, Khoury HJ, Talpaz M, DiPersio J, DeAngelo DJ, Abruzzese E, Rea D, Baccarani M, Müller MC, Gambacorti-Passerini C, Wong S, Lustgarten S, Rivera VM, Clackson T, Turner CD, Haluska FG, Guilhot F, Deininger MW, Hochhaus A, Hughes T, Goldman JM, Shah NP, Kantarjian H; PACE Investigators.

N Engl J Med. 2013 Nov 7;369(19):1783-96. doi: 10.1056/NEJMoa1306494. Epub 2013 Nov 1.

17.

Tyrosine kinase inhibitor usage, treatment outcome, and prognostic scores in CML: report from the population-based Swedish CML registry.

Höglund M, Sandin F, Hellström K, Björeman M, Björkholm M, Brune M, Dreimane A, Ekblom M, Lehmann S, Ljungman P, Malm C, Markevärn B, Myhr-Eriksson K, Ohm L, Olsson-Strömberg U, Själander A, Wadenvik H, Simonsson B, Stenke L, Richter J.

Blood. 2013 Aug 15;122(7):1284-92. doi: 10.1182/blood-2013-04-495598. Epub 2013 Jul 10.

18.

Motor control of the trunk during a modified clean and jerk lift.

Eriksson Crommert M, Ekblom MM, Thorstensson A.

Scand J Med Sci Sports. 2014 Oct;24(5):758-63. doi: 10.1111/sms.12064. Epub 2013 Mar 15.

PMID:
23489349
19.

Expression of integrin α2 receptor in human cord blood CD34+CD38-CD90+ stem cells engrafting long-term in NOD/SCID-IL2Rγ(c) null mice.

Wong WM, Sigvardsson M, Åstrand-Grundström I, Hogge D, Larsson J, Qian H, Ekblom M.

Stem Cells. 2013 Feb;31(2):360-71. doi: 10.1002/stem.1282.

20.

Killer-cell immunoglobulin-like receptor gene profile predicts good molecular response to dasatinib therapy in chronic myeloid leukemia.

Kreutzman A, Jaatinen T, Greco D, Vakkila E, Richter J, Ekblom M, Hjorth-Hansen H, Stenke L, Melo T, Paquette R, Seggewiss-Bernhardt R, Guerci-Bresler A, Talbot A, Cayuela JM, Mahon FX, Porkka K, Lipton J, Partanen J, Rousselot P, Mustjoki S.

Exp Hematol. 2012 Nov;40(11):906-913.e1. doi: 10.1016/j.exphem.2012.07.007. Epub 2012 Jul 25.

PMID:
22842045

Supplemental Content

Loading ...
Support Center